Pacific Bio (PACB) Tops Q2 EPS by 6c, beats revenue

Pacific Bio (NASDAQ: PACB) reported Q2 EPS of ($0.26), $0.06 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $47.57 million versus the consensus estimate of $40.2 million.

For earnings history and earnings-related data on Pacific Bio (PACB) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
• Air France-KLM (AF:FP) (AFLYY) PT Raised to EUR13.50 at UBS